Prof. Marco Falcone
University of Pisa,

Italy

‘The evolving landscape of Gram-negative resistance’

Prof. Stefania Stefani 
University Hospital Catania,

Italy

‘Cefiderocol: What’s different about a siderophore cephalosporin?’

Prof. Ricard Ferrer 

Vall d’Hebron University Hospital Barcelona, Spain

‘APEKS & CREDIBLE-CR: Lessons learned from a Gram-negative focused clinical development programme’

Prof. Sarah Tschudin Sutter, MD MSc

University Hospital Basel, Switzerland

‘Case report: Early clinical experience in the use of cefiderocol’ 

Prof. Aurélien Dinh

Hôpital Raymond-Poincaré, Garches, APHP Paris Saclay Université, France

‘Case report: Prosthetic joint infection with Gram-negative multidrug-resistant organisms'

Prof. Marco Falcone 

University of Pisa,

Italy

‘Case report: Early clinical experience in the use of cefiderocol — Acinetobacter baumannii’

Prof. Bavaro Davide Fiore, MD

University Hospital of Bari,

Italy

‘Recurrent neurosurgical site infection by XDR Pseudomonas aeruginosa treated with cefiderocol’

Dr Temi Lampejo

King’s College Hospital, London, UK

‘Cefiderocol for the treatment of a systemic infection due to carbapenemase-producing multidrug-resistant Klebsiella pneumoniae’

Dr Christopher Longshaw 

Shionogi B.V., 
London, UK

‘In vitro activity of cefiderocol and comparator antimicrobials against carbapenem-non-susceptible Gram-negative isolates from Europe’

Prof. Marco Falcone

University of Pisa,

Italy